Blockade of thymic stromal lymphopoietin (TSLP) receptor inhibits TSLP-driven proliferation and signalling in lymphoblasts from a subset of B-precursor ALL patients
• Lymphoblasts from roughly 20% of B cell precursor ALL patients express the TSLP receptor. • TSLP triggers proliferation and JAK/STAT-mediated gene regulation in TSLPR+ BCP-ALL cells. • TSLPR inhibition represses proliferation and STAT activity in TSLPR+ BCP-ALL cells. • Blockade of the TSLPR is a...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Vetter, Tina [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2016 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
6 |
|---|
| Übergeordnetes Werk: |
Enthalten in: N - Li, Danyang ELSEVIER, 2019, clinical and laboratory studies, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:40 ; year:2016 ; pages:38-43 ; extent:6 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.leukres.2015.10.003 |
|---|
| Katalog-ID: |
ELV035047550 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV035047550 | ||
| 003 | DE-627 | ||
| 005 | 20230624020459.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180603s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.leukres.2015.10.003 |2 doi | |
| 028 | 5 | 2 | |a GBVA2016003000009.pica |
| 035 | |a (DE-627)ELV035047550 | ||
| 035 | |a (ELSEVIER)S0145-2126(15)30395-7 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 333.7 |a 610 |q VZ |
| 084 | |a 43.12 |2 bkl | ||
| 084 | |a 43.13 |2 bkl | ||
| 084 | |a 44.13 |2 bkl | ||
| 100 | 1 | |a Vetter, Tina |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Blockade of thymic stromal lymphopoietin (TSLP) receptor inhibits TSLP-driven proliferation and signalling in lymphoblasts from a subset of B-precursor ALL patients |
| 264 | 1 | |c 2016 | |
| 300 | |a 6 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a • Lymphoblasts from roughly 20% of B cell precursor ALL patients express the TSLP receptor. • TSLP triggers proliferation and JAK/STAT-mediated gene regulation in TSLPR+ BCP-ALL cells. • TSLPR inhibition represses proliferation and STAT activity in TSLPR+ BCP-ALL cells. • Blockade of the TSLPR is a potential therapeutic option for a subset of BCP-ALL patients. | ||
| 650 | 7 | |a TSLP |2 Elsevier | |
| 650 | 7 | |a Cytokine receptors |2 Elsevier | |
| 650 | 7 | |a B-precursor ALL |2 Elsevier | |
| 650 | 7 | |a Inhibitory antibody |2 Elsevier | |
| 700 | 1 | |a Borowski, Andreas |4 oth | |
| 700 | 1 | |a Wohlmann, Andreas |4 oth | |
| 700 | 1 | |a Ranjan, Nilabh |4 oth | |
| 700 | 1 | |a Kuepper, Michael |4 oth | |
| 700 | 1 | |a Badura, Susanne |4 oth | |
| 700 | 1 | |a Ottmann, Oliver G. |4 oth | |
| 700 | 1 | |a Friedrich, Karlheinz |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier Science |a Li, Danyang ELSEVIER |t N |d 2019 |d clinical and laboratory studies |g Amsterdam [u.a.] |w (DE-627)ELV002185202 |
| 773 | 1 | 8 | |g volume:40 |g year:2016 |g pages:38-43 |g extent:6 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.leukres.2015.10.003 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OPC-GGO | ||
| 936 | b | k | |a 43.12 |j Umweltchemie |q VZ |
| 936 | b | k | |a 43.13 |j Umwelttoxikologie |q VZ |
| 936 | b | k | |a 44.13 |j Medizinische Ökologie |q VZ |
| 951 | |a AR | ||
| 952 | |d 40 |j 2016 |h 38-43 |g 6 | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
t v tv |
|---|---|
| matchkey_str |
vettertinaborowskiandreaswohlmannandreas:2016----:lcaefhmctoalmhpitnspeetrniissprvnrlfrtoadinlignypols |
| hierarchy_sort_str |
2016 |
| bklnumber |
43.12 43.13 44.13 |
| publishDate |
2016 |
| allfields |
10.1016/j.leukres.2015.10.003 doi GBVA2016003000009.pica (DE-627)ELV035047550 (ELSEVIER)S0145-2126(15)30395-7 DE-627 ger DE-627 rakwb eng 610 610 DE-600 333.7 610 VZ 43.12 bkl 43.13 bkl 44.13 bkl Vetter, Tina verfasserin aut Blockade of thymic stromal lymphopoietin (TSLP) receptor inhibits TSLP-driven proliferation and signalling in lymphoblasts from a subset of B-precursor ALL patients 2016 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Lymphoblasts from roughly 20% of B cell precursor ALL patients express the TSLP receptor. • TSLP triggers proliferation and JAK/STAT-mediated gene regulation in TSLPR+ BCP-ALL cells. • TSLPR inhibition represses proliferation and STAT activity in TSLPR+ BCP-ALL cells. • Blockade of the TSLPR is a potential therapeutic option for a subset of BCP-ALL patients. TSLP Elsevier Cytokine receptors Elsevier B-precursor ALL Elsevier Inhibitory antibody Elsevier Borowski, Andreas oth Wohlmann, Andreas oth Ranjan, Nilabh oth Kuepper, Michael oth Badura, Susanne oth Ottmann, Oliver G. oth Friedrich, Karlheinz oth Enthalten in Elsevier Science Li, Danyang ELSEVIER N 2019 clinical and laboratory studies Amsterdam [u.a.] (DE-627)ELV002185202 volume:40 year:2016 pages:38-43 extent:6 https://doi.org/10.1016/j.leukres.2015.10.003 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-GGO 43.12 Umweltchemie VZ 43.13 Umwelttoxikologie VZ 44.13 Medizinische Ökologie VZ AR 40 2016 38-43 6 045F 610 |
| spelling |
10.1016/j.leukres.2015.10.003 doi GBVA2016003000009.pica (DE-627)ELV035047550 (ELSEVIER)S0145-2126(15)30395-7 DE-627 ger DE-627 rakwb eng 610 610 DE-600 333.7 610 VZ 43.12 bkl 43.13 bkl 44.13 bkl Vetter, Tina verfasserin aut Blockade of thymic stromal lymphopoietin (TSLP) receptor inhibits TSLP-driven proliferation and signalling in lymphoblasts from a subset of B-precursor ALL patients 2016 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Lymphoblasts from roughly 20% of B cell precursor ALL patients express the TSLP receptor. • TSLP triggers proliferation and JAK/STAT-mediated gene regulation in TSLPR+ BCP-ALL cells. • TSLPR inhibition represses proliferation and STAT activity in TSLPR+ BCP-ALL cells. • Blockade of the TSLPR is a potential therapeutic option for a subset of BCP-ALL patients. TSLP Elsevier Cytokine receptors Elsevier B-precursor ALL Elsevier Inhibitory antibody Elsevier Borowski, Andreas oth Wohlmann, Andreas oth Ranjan, Nilabh oth Kuepper, Michael oth Badura, Susanne oth Ottmann, Oliver G. oth Friedrich, Karlheinz oth Enthalten in Elsevier Science Li, Danyang ELSEVIER N 2019 clinical and laboratory studies Amsterdam [u.a.] (DE-627)ELV002185202 volume:40 year:2016 pages:38-43 extent:6 https://doi.org/10.1016/j.leukres.2015.10.003 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-GGO 43.12 Umweltchemie VZ 43.13 Umwelttoxikologie VZ 44.13 Medizinische Ökologie VZ AR 40 2016 38-43 6 045F 610 |
| allfields_unstemmed |
10.1016/j.leukres.2015.10.003 doi GBVA2016003000009.pica (DE-627)ELV035047550 (ELSEVIER)S0145-2126(15)30395-7 DE-627 ger DE-627 rakwb eng 610 610 DE-600 333.7 610 VZ 43.12 bkl 43.13 bkl 44.13 bkl Vetter, Tina verfasserin aut Blockade of thymic stromal lymphopoietin (TSLP) receptor inhibits TSLP-driven proliferation and signalling in lymphoblasts from a subset of B-precursor ALL patients 2016 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Lymphoblasts from roughly 20% of B cell precursor ALL patients express the TSLP receptor. • TSLP triggers proliferation and JAK/STAT-mediated gene regulation in TSLPR+ BCP-ALL cells. • TSLPR inhibition represses proliferation and STAT activity in TSLPR+ BCP-ALL cells. • Blockade of the TSLPR is a potential therapeutic option for a subset of BCP-ALL patients. TSLP Elsevier Cytokine receptors Elsevier B-precursor ALL Elsevier Inhibitory antibody Elsevier Borowski, Andreas oth Wohlmann, Andreas oth Ranjan, Nilabh oth Kuepper, Michael oth Badura, Susanne oth Ottmann, Oliver G. oth Friedrich, Karlheinz oth Enthalten in Elsevier Science Li, Danyang ELSEVIER N 2019 clinical and laboratory studies Amsterdam [u.a.] (DE-627)ELV002185202 volume:40 year:2016 pages:38-43 extent:6 https://doi.org/10.1016/j.leukres.2015.10.003 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-GGO 43.12 Umweltchemie VZ 43.13 Umwelttoxikologie VZ 44.13 Medizinische Ökologie VZ AR 40 2016 38-43 6 045F 610 |
| allfieldsGer |
10.1016/j.leukres.2015.10.003 doi GBVA2016003000009.pica (DE-627)ELV035047550 (ELSEVIER)S0145-2126(15)30395-7 DE-627 ger DE-627 rakwb eng 610 610 DE-600 333.7 610 VZ 43.12 bkl 43.13 bkl 44.13 bkl Vetter, Tina verfasserin aut Blockade of thymic stromal lymphopoietin (TSLP) receptor inhibits TSLP-driven proliferation and signalling in lymphoblasts from a subset of B-precursor ALL patients 2016 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Lymphoblasts from roughly 20% of B cell precursor ALL patients express the TSLP receptor. • TSLP triggers proliferation and JAK/STAT-mediated gene regulation in TSLPR+ BCP-ALL cells. • TSLPR inhibition represses proliferation and STAT activity in TSLPR+ BCP-ALL cells. • Blockade of the TSLPR is a potential therapeutic option for a subset of BCP-ALL patients. TSLP Elsevier Cytokine receptors Elsevier B-precursor ALL Elsevier Inhibitory antibody Elsevier Borowski, Andreas oth Wohlmann, Andreas oth Ranjan, Nilabh oth Kuepper, Michael oth Badura, Susanne oth Ottmann, Oliver G. oth Friedrich, Karlheinz oth Enthalten in Elsevier Science Li, Danyang ELSEVIER N 2019 clinical and laboratory studies Amsterdam [u.a.] (DE-627)ELV002185202 volume:40 year:2016 pages:38-43 extent:6 https://doi.org/10.1016/j.leukres.2015.10.003 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-GGO 43.12 Umweltchemie VZ 43.13 Umwelttoxikologie VZ 44.13 Medizinische Ökologie VZ AR 40 2016 38-43 6 045F 610 |
| allfieldsSound |
10.1016/j.leukres.2015.10.003 doi GBVA2016003000009.pica (DE-627)ELV035047550 (ELSEVIER)S0145-2126(15)30395-7 DE-627 ger DE-627 rakwb eng 610 610 DE-600 333.7 610 VZ 43.12 bkl 43.13 bkl 44.13 bkl Vetter, Tina verfasserin aut Blockade of thymic stromal lymphopoietin (TSLP) receptor inhibits TSLP-driven proliferation and signalling in lymphoblasts from a subset of B-precursor ALL patients 2016 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Lymphoblasts from roughly 20% of B cell precursor ALL patients express the TSLP receptor. • TSLP triggers proliferation and JAK/STAT-mediated gene regulation in TSLPR+ BCP-ALL cells. • TSLPR inhibition represses proliferation and STAT activity in TSLPR+ BCP-ALL cells. • Blockade of the TSLPR is a potential therapeutic option for a subset of BCP-ALL patients. TSLP Elsevier Cytokine receptors Elsevier B-precursor ALL Elsevier Inhibitory antibody Elsevier Borowski, Andreas oth Wohlmann, Andreas oth Ranjan, Nilabh oth Kuepper, Michael oth Badura, Susanne oth Ottmann, Oliver G. oth Friedrich, Karlheinz oth Enthalten in Elsevier Science Li, Danyang ELSEVIER N 2019 clinical and laboratory studies Amsterdam [u.a.] (DE-627)ELV002185202 volume:40 year:2016 pages:38-43 extent:6 https://doi.org/10.1016/j.leukres.2015.10.003 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-GGO 43.12 Umweltchemie VZ 43.13 Umwelttoxikologie VZ 44.13 Medizinische Ökologie VZ AR 40 2016 38-43 6 045F 610 |
| language |
English |
| source |
Enthalten in N Amsterdam [u.a.] volume:40 year:2016 pages:38-43 extent:6 |
| sourceStr |
Enthalten in N Amsterdam [u.a.] volume:40 year:2016 pages:38-43 extent:6 |
| format_phy_str_mv |
Article |
| bklname |
Umweltchemie Umwelttoxikologie Medizinische Ökologie |
| institution |
findex.gbv.de |
| topic_facet |
TSLP Cytokine receptors B-precursor ALL Inhibitory antibody |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
N |
| authorswithroles_txt_mv |
Vetter, Tina @@aut@@ Borowski, Andreas @@oth@@ Wohlmann, Andreas @@oth@@ Ranjan, Nilabh @@oth@@ Kuepper, Michael @@oth@@ Badura, Susanne @@oth@@ Ottmann, Oliver G. @@oth@@ Friedrich, Karlheinz @@oth@@ |
| publishDateDaySort_date |
2016-01-01T00:00:00Z |
| hierarchy_top_id |
ELV002185202 |
| dewey-sort |
3610 |
| id |
ELV035047550 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV035047550</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624020459.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.leukres.2015.10.003</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2016003000009.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV035047550</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0145-2126(15)30395-7</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">333.7</subfield><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">43.12</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">43.13</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.13</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Vetter, Tina</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Blockade of thymic stromal lymphopoietin (TSLP) receptor inhibits TSLP-driven proliferation and signalling in lymphoblasts from a subset of B-precursor ALL patients</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">6</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• Lymphoblasts from roughly 20% of B cell precursor ALL patients express the TSLP receptor. • TSLP triggers proliferation and JAK/STAT-mediated gene regulation in TSLPR+ BCP-ALL cells. • TSLPR inhibition represses proliferation and STAT activity in TSLPR+ BCP-ALL cells. • Blockade of the TSLPR is a potential therapeutic option for a subset of BCP-ALL patients.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">TSLP</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cytokine receptors</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">B-precursor ALL</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Inhibitory antibody</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Borowski, Andreas</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wohlmann, Andreas</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ranjan, Nilabh</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kuepper, Michael</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Badura, Susanne</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ottmann, Oliver G.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Friedrich, Karlheinz</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Li, Danyang ELSEVIER</subfield><subfield code="t">N</subfield><subfield code="d">2019</subfield><subfield code="d">clinical and laboratory studies</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV002185202</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:40</subfield><subfield code="g">year:2016</subfield><subfield code="g">pages:38-43</subfield><subfield code="g">extent:6</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.leukres.2015.10.003</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-GGO</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">43.12</subfield><subfield code="j">Umweltchemie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">43.13</subfield><subfield code="j">Umwelttoxikologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.13</subfield><subfield code="j">Medizinische Ökologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">40</subfield><subfield code="j">2016</subfield><subfield code="h">38-43</subfield><subfield code="g">6</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Vetter, Tina |
| spellingShingle |
Vetter, Tina ddc 610 ddc 333.7 bkl 43.12 bkl 43.13 bkl 44.13 Elsevier TSLP Elsevier Cytokine receptors Elsevier B-precursor ALL Elsevier Inhibitory antibody Blockade of thymic stromal lymphopoietin (TSLP) receptor inhibits TSLP-driven proliferation and signalling in lymphoblasts from a subset of B-precursor ALL patients |
| authorStr |
Vetter, Tina |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV002185202 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health 333 - Economics of land & energy |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 333.7 610 VZ 43.12 bkl 43.13 bkl 44.13 bkl Blockade of thymic stromal lymphopoietin (TSLP) receptor inhibits TSLP-driven proliferation and signalling in lymphoblasts from a subset of B-precursor ALL patients TSLP Elsevier Cytokine receptors Elsevier B-precursor ALL Elsevier Inhibitory antibody Elsevier |
| topic |
ddc 610 ddc 333.7 bkl 43.12 bkl 43.13 bkl 44.13 Elsevier TSLP Elsevier Cytokine receptors Elsevier B-precursor ALL Elsevier Inhibitory antibody |
| topic_unstemmed |
ddc 610 ddc 333.7 bkl 43.12 bkl 43.13 bkl 44.13 Elsevier TSLP Elsevier Cytokine receptors Elsevier B-precursor ALL Elsevier Inhibitory antibody |
| topic_browse |
ddc 610 ddc 333.7 bkl 43.12 bkl 43.13 bkl 44.13 Elsevier TSLP Elsevier Cytokine receptors Elsevier B-precursor ALL Elsevier Inhibitory antibody |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
a b ab a w aw n r nr m k mk s b sb o g o og ogo k f kf |
| hierarchy_parent_title |
N |
| hierarchy_parent_id |
ELV002185202 |
| dewey-tens |
610 - Medicine & health 330 - Economics |
| hierarchy_top_title |
N |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV002185202 |
| title |
Blockade of thymic stromal lymphopoietin (TSLP) receptor inhibits TSLP-driven proliferation and signalling in lymphoblasts from a subset of B-precursor ALL patients |
| ctrlnum |
(DE-627)ELV035047550 (ELSEVIER)S0145-2126(15)30395-7 |
| title_full |
Blockade of thymic stromal lymphopoietin (TSLP) receptor inhibits TSLP-driven proliferation and signalling in lymphoblasts from a subset of B-precursor ALL patients |
| author_sort |
Vetter, Tina |
| journal |
N |
| journalStr |
N |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology 300 - Social sciences |
| recordtype |
marc |
| publishDateSort |
2016 |
| contenttype_str_mv |
zzz |
| container_start_page |
38 |
| author_browse |
Vetter, Tina |
| container_volume |
40 |
| physical |
6 |
| class |
610 610 DE-600 333.7 610 VZ 43.12 bkl 43.13 bkl 44.13 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Vetter, Tina |
| doi_str_mv |
10.1016/j.leukres.2015.10.003 |
| dewey-full |
610 333.7 |
| title_sort |
blockade of thymic stromal lymphopoietin (tslp) receptor inhibits tslp-driven proliferation and signalling in lymphoblasts from a subset of b-precursor all patients |
| title_auth |
Blockade of thymic stromal lymphopoietin (TSLP) receptor inhibits TSLP-driven proliferation and signalling in lymphoblasts from a subset of B-precursor ALL patients |
| abstract |
• Lymphoblasts from roughly 20% of B cell precursor ALL patients express the TSLP receptor. • TSLP triggers proliferation and JAK/STAT-mediated gene regulation in TSLPR+ BCP-ALL cells. • TSLPR inhibition represses proliferation and STAT activity in TSLPR+ BCP-ALL cells. • Blockade of the TSLPR is a potential therapeutic option for a subset of BCP-ALL patients. |
| abstractGer |
• Lymphoblasts from roughly 20% of B cell precursor ALL patients express the TSLP receptor. • TSLP triggers proliferation and JAK/STAT-mediated gene regulation in TSLPR+ BCP-ALL cells. • TSLPR inhibition represses proliferation and STAT activity in TSLPR+ BCP-ALL cells. • Blockade of the TSLPR is a potential therapeutic option for a subset of BCP-ALL patients. |
| abstract_unstemmed |
• Lymphoblasts from roughly 20% of B cell precursor ALL patients express the TSLP receptor. • TSLP triggers proliferation and JAK/STAT-mediated gene regulation in TSLPR+ BCP-ALL cells. • TSLPR inhibition represses proliferation and STAT activity in TSLPR+ BCP-ALL cells. • Blockade of the TSLPR is a potential therapeutic option for a subset of BCP-ALL patients. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-GGO |
| title_short |
Blockade of thymic stromal lymphopoietin (TSLP) receptor inhibits TSLP-driven proliferation and signalling in lymphoblasts from a subset of B-precursor ALL patients |
| url |
https://doi.org/10.1016/j.leukres.2015.10.003 |
| remote_bool |
true |
| author2 |
Borowski, Andreas Wohlmann, Andreas Ranjan, Nilabh Kuepper, Michael Badura, Susanne Ottmann, Oliver G. Friedrich, Karlheinz |
| author2Str |
Borowski, Andreas Wohlmann, Andreas Ranjan, Nilabh Kuepper, Michael Badura, Susanne Ottmann, Oliver G. Friedrich, Karlheinz |
| ppnlink |
ELV002185202 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth |
| doi_str |
10.1016/j.leukres.2015.10.003 |
| up_date |
2024-07-06T22:40:03.105Z |
| _version_ |
1803871168083525632 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV035047550</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624020459.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.leukres.2015.10.003</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2016003000009.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV035047550</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0145-2126(15)30395-7</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">333.7</subfield><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">43.12</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">43.13</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.13</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Vetter, Tina</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Blockade of thymic stromal lymphopoietin (TSLP) receptor inhibits TSLP-driven proliferation and signalling in lymphoblasts from a subset of B-precursor ALL patients</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">6</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• Lymphoblasts from roughly 20% of B cell precursor ALL patients express the TSLP receptor. • TSLP triggers proliferation and JAK/STAT-mediated gene regulation in TSLPR+ BCP-ALL cells. • TSLPR inhibition represses proliferation and STAT activity in TSLPR+ BCP-ALL cells. • Blockade of the TSLPR is a potential therapeutic option for a subset of BCP-ALL patients.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">TSLP</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cytokine receptors</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">B-precursor ALL</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Inhibitory antibody</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Borowski, Andreas</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wohlmann, Andreas</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ranjan, Nilabh</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kuepper, Michael</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Badura, Susanne</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ottmann, Oliver G.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Friedrich, Karlheinz</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Li, Danyang ELSEVIER</subfield><subfield code="t">N</subfield><subfield code="d">2019</subfield><subfield code="d">clinical and laboratory studies</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV002185202</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:40</subfield><subfield code="g">year:2016</subfield><subfield code="g">pages:38-43</subfield><subfield code="g">extent:6</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.leukres.2015.10.003</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-GGO</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">43.12</subfield><subfield code="j">Umweltchemie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">43.13</subfield><subfield code="j">Umwelttoxikologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.13</subfield><subfield code="j">Medizinische Ökologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">40</subfield><subfield code="j">2016</subfield><subfield code="h">38-43</subfield><subfield code="g">6</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.401187 |